Infusion-related risks associated with chemotherapy
Intended for healthcare professionals
CPD Previous     Next

Infusion-related risks associated with chemotherapy

Elizabeth Gallimore Oncology research practitioner, Clatterbridge Cancer Centre, Merseyside, England

This article provides a comprehensive overview of the risks associated with the administration of chemotherapy, monoclonal antibodies and targeted or biological therapies in the management of solid tumours. The main physiological actions of these agents are discussed, with reference to the immediate infusion-related side effects and complications that may arise from an extravasation injury. The article focuses on the identification and early recognition of these risk factors to implement preventive measures and appropriate management strategies.

Nursing Standard. 30, 25, 51-60. doi: 10.7748/ns.30.25.51.s48

Correspondence

lizzy.gallimore@hotmail.com

Peer review

All articles are subject to external double-blind peer review and checked for plagiarism using automated software.

Received: 29 May 2015

Accepted: 07 October 2015

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more